Stem Cell Banking Market- Global Industry Analysis and Forecast (2022-2029) Trends, Statistics, Dynamics, Segment Analysis

Stem Cell Banking Market was valued at US$ 10.08 Bn. in 2022. The global Stem cell banking Market size is expected to grow at a CAGR of 8.4% through the forecast period.
Stem Cell Banking Market Overview:
The process of removing priceless stem cells from the human body, processing them, and storing them in consideration of eventual use in stem cell therapies is known as stem cell banking. low temperatures are used in stem cell banks to maintain the biological characteristics of stem cells and shield them from contamination and deterioration. Any stem cell bank that wants to store cells for longer periods without losing their qualities must follow standardized, quality-controlled preservation processes.To know about the Research Methodology:-Request Free Sample Report
Impact of Covid-19 on the Stem Cell Banking Market
The growth of the stem cell banking sector is estimated to be negatively impacted by the COVID-19 epidemic. Additionally, COVID-19 led to a serious public health issue. To contain the COVID-19 pandemic outbreak, the government imposed a lockdown and social segregation restrictions, which halted various stem cell harvesting processes, disrupted the supply chain, stunted business growth, canceled technology events, suspended new developments, and had an impact on overall production and sales. On the plus side, stem cell clinical studies for COVID-19 treatment may help the market recover quickly after the pandemic. The market will experience profitable improvement as clinical trials for the use of stem cells in treatment gradually increase.
Stem Cell Banking Market Dynamics:
The Growing Need for Stem Cell Banking

The two most important aspects fueling this market's growth are the development of stem cell banking for treating severely damaged tissues and the rising burden of major diseases. The market's overall growth is anticipated to be accelerated by the surge in hematopoietic stem cell transplantations, as well as by the rise in skin and brain cell transplantations.

Increased awareness

Multiple activities by governmental and non-governmental groups to raise consumer knowledge of the therapeutic potentials of stem cells will support the market's overall growth. Additionally, it is expected that the market will grow as a result of population growth and the development of the business world. Additionally, the increase of the market during the expected time is tempered by the rise in the respective underdeveloped and developing economies' gross domestic products (GDP). The market is expected to increase as more clinical studies for stem cell research are approved.

Increasing Investments and Progress

the market is expected to benefit greatly from the development of breakthrough technologies for stem cell preservation, processing, and storage. Numerous market growth potentials will also be provided by the growing investments in stem cell-based research.

High Costs in the Stem Cell Banking Market

On the other hand, it is expected that the high operating expenses of stem cell transplantation will restrain the market growth. Additionally, from 2023 to 2029, the strict regulatory frameworks and socio-ethical considerations surrounding embryonic stem cells are anticipated to pose a challenge to the stem cell banking market. This stem cell banking market report details recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, and the impact of domestic and localized market players. It also analyses opportunities in terms of new revenue pockets, regulatory changes, strategic market growth analysis, market size, category market growths, application niches, and dominance, product approvals, product launches, and geospatial data.
Stem Cell Banking Market Segment Analysis:
Based on Type: The Stem Cell Banking Market is segmented into cord blood and cord tissue based on the kind of bank. This market is dominated by cord blood types because of its implications. During the expected period, the court issue section is anticipated to expand at a respectable rate as well. The blood that stays in the placenta and umbilical cord after birth is known as cord blood. After the birthing plan is agreed upon with the doctor, the umbilical cord is clamped and severed, leaving an average of 80–120 milliliters, or around 1/3–1/2 cup, of blood inside. Using a surgical needle, the blood still presents in the cord and the placenta is extracted and placed in a collection bag. Even while the amount of blood that was drawn seemed insignificant, it included millions of a certain kind of adult stem cells that can later develop into the blood and immune system.

Cord tissue

Wharton's jelly-like substance that surrounds the vessels of the umbilical cord is called cord tissue. The umbilical cord will be clamped and severed during birth, and a segment of it (often a bit about four inches long) can then be kept. Millions of various stem cells that develop into a person's neurological system, sensory organs, circulatory tissues, skin, bone, cartilage, and other body parts can be found in the cord tissue.Based on the Application, the Stem Cell Banking Market is segmented into Leukemia, Diabetes, Autism, Cerebral Palsy, Thalassemia, and Others based on the application. Due to the increase in people with both conditions, diabetes is leading the market. In comparison to other segments, it is expected that the diabetes segment would develop at the fastest CAGR.

The first disease for which stem cell transplants were used to treat was leukemia. A stem cell transplant can be utilized to swap out the cancerous blood-forming cells that are present in the bone marrow for non-malignant ones when the disease is advanced and requires chemotherapy. Stem cell transplants are only explored when standard-dose chemotherapy fails to eradicate leukemia since they are intense and can leave patients exposed to infections and other problems. To treat specific types of acute leukemia, however, hematopoietic cell transplantation has shown to be highly effective. Patients with leukemia may benefit greatly from using umbilical cord blood as a source of stem cells.
Stem cell banking Market Regional Insights:
Asia-Pacific is expected to experience significant growth between 2023 and 2029 Due to the region's expanding healthcare infrastructure and growing patient population,

The Asia Pacific region is expected to witness significant growth at a CAGR of 3.4% throughout the period, North America currently has a dominant position in the stem cell banking market. Due to the prevalence of chronic diseases and the growing network of stem cell banking services in the region. The Asia Pacific is anticipated to have considerable growth in the stem cell banking market. This is due to factors including the ability to pay for stem cell banking in monthly installments, which makes it accessible to a wide range of people, and rising birth rates together with an increase in the occurrence of birth abnormalities. For instance, India has a soaring birth rate of 26 million per year, which is assisting in the growth of the business, according to the t012 Save the Children India report. According to Multicenter Study, 2013, there is a strong demand for stem cell banking in India where 10,000 to 15,000 infants have been diagnosed with thalassemia and sickle Anaemia.

The objective of the report is to present a comprehensive analysis of the global Stem cell banking Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Stem cell banking Market dynamic, and structure by analyzing the market segments and projecting the Stem cell banking Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Stem cell banking Market make the report investor’s guide.
Stem cell banking Market Scope: Inquire before buying



Stem Cell Banking Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2017 to 2022
Market Size in 2022:
US $ 10.08 Bn.


Forecast Period 2023 to 2029 CAGR:
8.4%
Market Size in 2029:
US $ 16.36 Bn.


 Segments Covered:
by Type
• Cord Blood
• Cord Tissue
• Others


by Application
• Leukemia
• Diabetes
• Autism
• Cerebral Palsy


by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)



Stem cell banking Market Key Players are:
• CBR Systems, Inc
• Cord life
• Cryo-cell international
• Via card
• StemCyte India Therapeutics
• Smart cell international
• Celgene corporation
• brainstorm cell limited
• cryoholdo
• Cryo-save
• Lifecell International Pvt.ltd
• Vita34197
• Caladrius Biosciences, inc
• global cord blood corporation
• regrow bioscience
• Ingredion Incorporated
• Sanstar Bio-Polymers Ltd.

Frequently Asked Questions:

1] What segments are covered in the Global Stem cell banking market report?
Ans. The segments covered in the Global Stem cell banking Market report are based on Product Type and Application.

2] Which region is expected to hold the highest share in the Global Stem cell banking Market?
Ans. The Asia Pacific region is expected to hold the highest share in the Global Stem cell banking Market.

3] What is the market size of the Global Stem cell banking Market by 2029?
Ans. The market size of the Global Stem cell banking Market by 2029 is expected to reach US$ 16.36 Bn.

4] What is the forecast period for the Global Stem cell banking Market?
Ans. The forecast period for the Global Stem cell banking Market is 2023-2029.

5] What was the market size of the Global Stem cell banking Market in 2022?
Ans. The market size of the Global Stem cell banking Market in 2022 was valued at US$ 10.08 Bn.